Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | CA9 | Q16790 | 1/20 | 0.59 |
| ▸ | IDO1 | P14902 | 9/20 | 0.52 |
| ▸ | NOS1 | P29475 | 2/20 | 0.52 |
| ▸ | NOS3 | P29474 | 1/20 | 0.52 |
| ▸ | NOS2 | P35228 | 1/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.49 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.49 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.49 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.49 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.49 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.49 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.49 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.49 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.49 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL36459 | 0.96 | CA12 (0.59) | CA12CA1CA2CA9IDO1 | |
| SCHEMBL20815367 | 0.94 | HDAC3 (0.56) | CA12CA1CA2CA9IDO1 | |
| SCHEMBL6721001 | 0.92 | CA12 (0.52) | CA12CA1CA2CA9IDO1 | |
| SCHEMBL1524417 | 0.91 | CA12 (0.53) | CA12CA1CA2CA9IDO1 | |
| SCHEMBL7584270 | 0.91 | L3MBTL1 (0.54) | CA12CA1CA2CA9IDO1 | |
| SCHEMBL4386352 | 0.91 | CA12 (0.50) | CA12CA1CA2CA9IDO1 | |
| SCHEMBL7573418 | 0.91 | CA12 (0.50) | CA12CA1CA2CA9IDO1 | |
| SCHEMBL28472436 | 0.87 | CA12 (0.59) | CA12CA1CA2CA9IDO1 | |
| SCHEMBL7572807 | 0.86 | MAOB (0.54) | CA12CA1CA2CA9IDO1 | |
| SCHEMBL2045957 | 0.86 | CA12 (0.46) | CA12CA1CA2CA9IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 261 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747339-A1 | INDUSTRIAL GEAR LUBRICANT | The Lubrizol Corporation (US) | 2026-05-27 | — | — | EP | disclosed |
| US-12624196-B2 | Rubber composition, vulcanized object obtained from said rubber composition, and vulcanized molded object obtained from said rubber composition | DENKA COMPANY LIMITED (JP) | 2026-05-12 | — | — | US | disclosed |
| US-12492279-B2 | Chloroprene-based block copolymer, latex, latex composition, and rubber composition | DENKA COMPANY LIMITED (JP) | 2025-12-09 | — | — | US | disclosed |
| US-20250269096-A1 | FLUOROPOLYMER MEDICAL DEVICES | UNOMEDICAL AS (DK) | 2025-08-28 | — | — | US | disclosed |
| EP-4282889-B1 | (METH)ACRYLIC BLOCK COPOLYMER, (METH)ACRYLIC BLOCK COPOLYMER LATEX, (METH)ACRYLIC BLOCK COPOLYMER LATEX COMPOSITION, AND SHAPED OBJECT | DENKA COMPANY LTD (JP) | 2025-08-20 | — | — | EP | disclosed |
| EP-4583933-A1 | FLUOROPOLYMER MEDICAL DEVICES | Unomedical A/S (DK) | 2025-07-16 | — | — | EP | disclosed |
| EP-4583934-A1 | MEDICAL DEVICES | Unomedical A/S (DK) | 2025-07-16 | — | — | EP | disclosed |
| US-20250195832-A1 | MEDICAL DEVICES | UNOMEDICAL AS (DK) | 2025-06-19 | — | — | US | disclosed |
| CN-115348982-B | Chloroprene block copolymer, latex composition, and rubber composition | 电化株式会社 | 2025-05-30 | — | — | CN | disclosed |
| US-12312433-B2 | Chloroprene-based block copolymer, latex, latex composition, and rubber composition | DENKA COMPANY LIMITED (JP) | 2025-05-27 | — | — | US | disclosed |
| EP-1833868-A2 | STAR POLYMERS AND COMPOSITIONS THEREOF | THE LUBRIZOL CORPORATION (US) | 2007-09-19 | — | — | EP | disclosed |
| EP-1403291-B1 | PROCESS FOR PRODUCING POLYMER HAVING CROSSLINKABLE SILYL GROUP AND CURABLE COMPOSITION | KANEKA CORP (JP) | 2007-08-29 | — | — | EP | disclosed |
| US-7250479-B2 | Polymerization with living characteristics | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-07-31 | — | — | US | disclosed |
| US-7250479-B2 | Polymerization with living characteristics | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-07-31 | — | — | US | disclosed |
| US-7250479-B2 | Polymerization with living characteristics | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-07-31 | — | — | US | disclosed |
| US-7211625-B2 | Thermoplastic resin composition and elastomer composition | KANEKA CORPORATION (JP) | 2007-05-01 | — | — | US | disclosed |
| WO-2006047398-A2 | STAR POLYMERS AND COMPOSITIONS THEREOF | THE LUBRIZOL CORPORATION (US) | 2006-05-04 | — | — | WO | disclosed |
| WO-2006047393-A1 | PROCESS FOR PREPARING POLYMERS AND COMPOSITIONS THEREOF | THE LUBRIZOL CORPORATION (US) | 2006-05-04 | — | — | WO | disclosed |
| EP-0910587-B1 | POLYMERIZATION WITH LIVING CHARACTERISTICS | DU PONT (US) | 2001-12-12 | — | — | EP | disclosed |
| US-4085094-A | SULFENYLTHIOCARBONATES | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1978-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624196-B2 | Rubber composition, vulcanized object obtained from said rubber composition, and vulcanized molded object obtained from said rubber composition | ALG3, VCL, DNMT1 | CA12 1062/4885CA1 315/4885CA2 982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.